Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting...